Clinical Trials
2 trialsNCT06740019 2025-04-04
A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Jemincare
Phase 1 Recruiting
NCT05375825 2024-02-02
Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn